Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age

Clinical trial NCT04642079 · COMPLETED

Trial details

NCT number: NCT04642079
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Disease

Start date: 2020-12-04
Primary completion: 2022-04-06
Enrollment: 839

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.